Clinical Outcomes With Extended Versus Intermittent Infusion of Anti-Pseudomonal Beta-Lactams in Patients With Gram-Negative Bacteremia

BACKGROUND: Administration of doses via an extended infusion (EI) is an important strategy to optimize beta-lactams. Available data on the impact of EI on outcomes largely focus on clinical cure or mortality in critically ill patients or those with resistant pathogens. The potential benefits of EI e...

Descripción completa

Detalles Bibliográficos
Autores principales: Tran, Nikki N, Mynatt, Ryan P, Kaye, Keith S, Zhao, Jing J, Pogue, Jason M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135424/
https://www.ncbi.nlm.nih.gov/pubmed/37125229
http://dx.doi.org/10.1093/ofid/ofad170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135424/
https://www.ncbi.nlm.nih.gov/pubmed/37125229
http://dx.doi.org/10.1093/ofid/ofad170

Ejemplares similares